Immuneering director granted 33,350 stock options
Immuneering Corp director Robert J. Carpenter received a grant of stock options for 33,350 shares of Class A common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Immuneering Corp director Robert J. Carpenter received a grant of stock options for 33,350 shares of Class A common stock. The options have an exercise price of $4.12 per share and expire on June 11, 2036. They vest in equal monthly installments over one year starting July 11, 2026, becoming fully vested by June 11, 2027 or the 2027 annual stockholder meeting, whichever occurs first. Following this grant, he holds 33,350 stock options directly.
Insider Trade Summary
Grant/Award: 33,350 shares
Grant/Award
1 txn
Insider
CARPENTER ROBERT J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 33,350 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 33,350 contracts (Direct)
Footnotes (1)
- F1. The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 11, 2026, and will be fully vested and exercisable on June 11, 2027, or the date of the 2027 annual meeting of stockholders, whichever comes first.
Key Figures
Options granted: 33,350 options
Exercise price: $4.12 per share
Expiration date: June 11, 2036
+3 more
6 metrics
Options granted
33,350 options
Stock option award to director Robert J. Carpenter
Exercise price
$4.12 per share
Strike price for Class A common stock underlying options
Expiration date
June 11, 2036
Option term end date
Vesting start
July 11, 2026
Monthly vesting commencement date
Full vest date
June 11, 2027
Or 2027 annual stockholder meeting, whichever first
Post-grant holdings
33,350 options
Total stock options held directly after grant
Key Terms
Stock Option, Class A Common Stock, exercise price, vests and becomes exercisable, +1 more
5 terms
Stock Option financial
"security_title: Stock Option"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
exercise price financial
"conversion_or_exercise_price: 4.1200"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vests and becomes exercisable financial
"The option vests and becomes exercisable in equal monthly installments"
expiration date financial
"expiration_date: 2036-06-11T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Immuneering Corp (IMRX) report for Robert J. Carpenter?
Immuneering reported that director Robert J. Carpenter received a grant of 33,350 stock options. These options relate to Class A common stock and were awarded as a compensation grant, not an open-market purchase or sale of existing shares.
What is the exercise price of Robert J. Carpenter’s new Immuneering (IMRX) stock options?
The granted stock options have an exercise price of $4.12 per share. This means Carpenter can buy Immuneering Class A common stock at $4.12 once the options vest and before they expire on June 11, 2036.
How and when do Robert J. Carpenter’s Immuneering (IMRX) options vest?
The 33,350 options vest in equal monthly installments over one year starting July 11, 2026. They will be fully vested by June 11, 2027 or on the date of the 2027 annual stockholder meeting, whichever occurs first.
When do Robert J. Carpenter’s Immuneering (IMRX) stock options expire?
The stock options granted to Robert J. Carpenter expire on June 11, 2036. He can exercise vested options any time before that expiration date, subject to the company’s equity plan and applicable trading and governance rules.
How many Immuneering (IMRX) stock options does Robert J. Carpenter hold after this grant?
After this grant, Carpenter holds 33,350 stock options directly. All of these options relate to Immuneering’s Class A common stock and were acquired through this single compensation award reported in the Form 4 filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
